Negative impactResults
Syngene International Q2 Results: Net profit tanks 52% on lower Zoetis revenue, forex hedge losses
CNBC-TV18 1 hr ago·27 Oct 2026, 5:10 pm
Syngene International reported a 52% drop in net profit for the second quarter of FY27, driven by a decline in revenue from its key client Zoetis and losses from foreign exchange hedging. The company's revenue fell by 8.6% to ₹833 crore, while its earnings margin also narrowed. Despite these challenges, Sygenes management highlighted progress on its new facilities, including a manufacturing agreement for the Bayview biologics site and a clinical supplies contract for its Bengaluru plant.
This earnings miss is notable as Zoetis is a major revenue driver for the company. While the new facility contracts are positive for long-term growth, the current decline in profit and margin highlights the impact of a key client's performance. Investors should monitor Sygenes ability to recover Zoetis revenue and how the new facilities contribute to future earnings growth.
Excerpt from CNBC-TV18
Published On Oct 27, 2026 | 22:40 IST Last Updated On Oct 27, 2026 | 22:40 IST Weaker partner revenue and currency hedges pulled down quarterly earnings, even as sequential revenue rebounded on stronger CDMO traction. The firm secured milestone biologics manufacturing contracts and advanced its AI-driven research…Read the original at CNBC-TV18
Affected stocks
Bearish1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Syngene International (SYNGENE).
- Category: Results.
- AI reads the tone as negative (potentially bearish) for the stock.
Why it matters
A routine update for Syngene International. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.
